title: Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes.
authors.forename: O
authors.initials: O
authors.lastname: van Oostrom
authors.forename: M
authors.initials: M
authors.lastname: Nieuwdorp
authors.forename: P E
authors.initials: PE
authors.lastname: Westerweel
authors.forename: I E
authors.initials: IE
authors.lastname: Hoefer
authors.forename: R
authors.initials: R
authors.lastname: Basser
authors.forename: E S G
authors.initials: ES
authors.lastname: Stroes
authors.forename: M C
authors.initials: MC
authors.lastname: Verhaar
mesh_terms: D000704:Analysis of Variance; D002465:Cell Movement / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000503:physiopathology; D042783:Endothelial Cells / Q000187:drug effects* / Q000502:physiology; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007262:Infusions, Intravenous; D008075:Lipoproteins, HDL / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011336:Probability; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D013234:Stem Cells / Q000187:drug effects* / Q000502:physiology
chemical_list: D008075:Lipoproteins, HDL